Different intervention strategies for preventing type 2 diabetes mellitus in China: A systematic review and network meta-analysis of randomized controlled trials

被引:11
|
作者
Pang, Bing [1 ]
Zhao, Lin-hua [1 ]
Li, Xin-long [2 ]
Song, Jun [1 ]
Li, Qing-wei [1 ]
Liao, Xing [2 ]
Feng, Shuo [3 ]
Zhao, Xi-yan [1 ]
Zheng, Yu-jiao [1 ]
Gou, Xiao-wen [1 ]
Ni, Qing [1 ]
Tong, Xiao-lin [1 ]
机构
[1] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Endocrinol, Room 802,Adm Bldg,5 Beixiange St, Beijing 100053, Peoples R China
[2] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Chinese subjects; different intervention strategies; network meta-analysis; prevention; type 2 diabetes mellitus; DISEASE; CDKAL1;
D O I
10.1111/dom.13121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Different strategies are increasingly used for early intervention in prediabetes in China, but the effects of these strategies on incident diabetes have not yet been confirmed. The aim of the present study was to assess systematically the effects of different strategies for preventing diabetes, aimed at Chinese people with prediabetes. Seven electronic databases were searched to identify eligible trials published from inception to September 20, 2016. Randomized controlled trials with a minimum follow-up duration of 6months were included. Standard pairwise meta-analysis with a random-effects model and network meta-analysis with a frequentist framework were performed. A total of 63 studies, including 11 intervention strategies, were included. Compared with placebo, all strategies, except for lipid-affecting drugs and sitagliptin, reduced the rate of incident diabetes with different levels of effectiveness, ranging from 0.18 (95% confidence interval [CI] 0.12, 0.27) to 0.39 (95% CI 0.20, 0.75). Ranking probability analysis indicated that metformin and -cell-stimulating drugs reduced the risk of diabetes most, with probabilities of 87.4% and 81%, respectively. Ethnicity and cultural factors should be considered for diabetes prevention. Most of the included trials were of poor methodological quality, however, and the results should be interpreted with caution.
引用
收藏
页码:718 / 722
页数:5
相关论文
共 50 条
  • [11] Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
    Aldekhail, N. M.
    Logue, J.
    McLoone, P.
    Morrison, D. S.
    OBESITY REVIEWS, 2015, 16 (12) : 1071 - 1080
  • [12] Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials
    Lu, Jiaping
    Ying, Zhen
    Wang, Ping
    Fu, Minjie
    Han, Chenyu
    Zhang, Min
    DIABETES OBESITY & METABOLISM, 2024, 26 (01) : 362 - 372
  • [13] The Effect of Diacerein on Type 2 Diabetic Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis
    Guo, Shizhe
    Guo, Xianshan
    Zhang, Hongya
    Zhang, Xuan'e
    Li, Zhen
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [14] Interventions for Preventing Chemotherapy-Induced Alopecia A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
    Zhou, Tong
    Han, Shuyu
    Zhu, Zheng
    Hu, Yan
    Xing, Weijie
    CANCER NURSING, 2021, 44 (06) : E567 - E577
  • [15] Preventing weight gain in adults: A systematic review and meta-analysis of randomized controlled trials
    Martin, Julie C.
    Awoke, Mamaru Ayenew
    Misso, Marie L.
    Moran, Lisa J.
    Harrison, Cheryce L.
    OBESITY REVIEWS, 2021, 22 (10)
  • [16] Comparative safety of different sodium-glucose transporter 2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials
    Li, Chun Xing
    Liu, Li Yan
    Zhang, Chen Xiao
    Geng, Xu Hua
    Gu, Si Meng
    Wang, Yu Qiao
    Liu, Hua
    Xie, Qing
    Liang, Shuo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [17] Effect of Metformin on Lipid Profiles of Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials
    Gillani, Syed Wasif
    Ghayedi, Nahal
    Roosta, Pardis
    Seddigh, Parvin
    Nasiri, Omaimah
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2021, 13 (01) : 76 - 82
  • [18] Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Parveen, Rizwana
    Hussain, Shadan
    Saini, Sparsh
    Khan, Parvej
    Saha, Nilanjan
    Nidhi
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, : 925 - 935
  • [19] Effects of Probiotic Supplementation on Dyslipidemia in Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
    Wang, Chen
    Zhang, Chengcheng
    Li, Sijia
    Yu, Leilei
    Tian, Fengwei
    Zhao, Jianxin
    Zhang, Hao
    Chen, Wei
    Zhai, Qixiao
    FOODS, 2020, 9 (11)
  • [20] Comparative effectiveness of bariatric surgeries in patients with obesity and type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials
    Ding, Li
    Fan, Yuxin
    Li, Hui
    Zhang, Yalan
    Qi, Dongwang
    Tang, Shaofang
    Cui, Jingqiu
    He, Qing
    Zhuo, Chuanjun
    Liu, Ming
    OBESITY REVIEWS, 2020, 21 (08)